Ultrasound Grayscale Analysis in ARDS covid19
Graycovid
Qualitative Muscular Ultrasound in covid19 ARDS Patients
1 other identifier
observational
32
1 country
1
Brief Summary
Recent evidence regarding the novel coronavirus disease 2019 (COVID19) is growing in describing the characteristics of this disease, with main focus on lung morphology. Few data are available regarding the peripheral and respiratory muscular characteristics. Using a ultrasound greyscale analysis, It Is possibile to evaluated the muscle quality. The hypothesis of this studi is that a combined assessment of respiratory (i.e., intercostal and diaphragm) and peripheral (i.e., quadriceps) muscles quantity (as measured by thickness) and quality (as assessed by greyscale analysis), would reflect the severity of illness. Thus,the aims of this study are to assess if the quality characteristics of parasternal intercostal, diaphragm and quadriceps muscles of ICU COVID19 patients influenced the outcomes and are correlated with other variables, such as fluid or protein balance, or indexes of inflammation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 21, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 21, 2021
CompletedFirst Submitted
Initial submission to the registry
April 22, 2021
CompletedFirst Posted
Study publicly available on registry
April 28, 2021
CompletedApril 28, 2021
April 1, 2021
11 months
April 22, 2021
April 26, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Grayscale and mortality
assess if the muscular grayscale of parasternal intercostal, diaphragm and quadriceps muscles of ICU COVID19 patients influenced the outcomes
One year
Secondary Outcomes (1)
Grayscale and inflammation
One year
Interventions
Muscular grayscale ultrasound
Eligibility Criteria
Ards covid19 icu patients
You may qualify if:
- \- intubated patients with confirmed infection by SARS COV 2 and diagnosis of ARDS
You may not qualify if:
- age less than 18 years, history of severe chronic obstructive pulmonary disease, pregnancy, failure to perform respiratory muscle ultrasound
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
ASST-Santi Paolo e Carlo, San Paolo Hospital
Milan, 20142, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PROFESSOR
Study Record Dates
First Submitted
April 22, 2021
First Posted
April 28, 2021
Study Start
April 1, 2020
Primary Completion
February 21, 2021
Study Completion
February 21, 2021
Last Updated
April 28, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share